An analysis of neighborhood-level data in three US cities highlights the racial and socioeconomic disparities in COVID-19 positivity, incidence, and mortality, researchers reported today in the Annals of Internal Medicine.
The European Commission this week published its latest annual progress report on implementation of the European One Health Action Plan against Antimicrobial Resistance (AMR).
A paper today in Morbidity and Mortality Weekly Reports (MMWR) describes the first US case of Neisseria gonorrhoeae harboring a genetic element that confers resistance to a first-line antibiotic.
CARB-X announced today that it is awarding $2.86 million to Microbiotix of Worcester, Massachusetts, to develop a new oral antibiotic for multidrug-resistant (MDR) gonorrhea.
Nearly one in five antibiotic prescriptions for hospitalized children in Australia is inappropriate, Australian researchers reported yesterday in the Journal of Antimicrobial Chemotherapy.
Officials in North Dakota confirmed chronic wasting disease (CWD) in two mule deer hunted in McKenzie County in the Badlands and in Divide County on the Canadian border. The former represents the first documented CWD case in the Badlands, while the disease was first detected in Divide County last fall.
An analysis of nationwide Veterans Health Administration data across 3 years finds that a large proportion of antimicrobial exposure among hospitalized patients occurs immediately following discharge, according to a study yesterday in Clinical Microbiology and Infection.
A study yesterday in Antimicrobial Agents and Chemotherapy details the emergence of gonorrhea strains with high-level resistance to azithromycin in Taiwan.
Solithromycin, a novel fourth-generation macrolide, isn't a suitable alternative to standard therapy of ceftriaxone plus azithromycin for treating gonorrhea, according to a study yesterday by researchers from Australia and the United States in The Lancet Infectious Diseases.
But gentamicin combined with azithromycin might be appropriate for some patients.
